Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Ah0003 50454

Tampa, Florida 33613, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Alzheimer disease

Closed trials

Completed
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
NCT04867616· Phase 2· UCB Biopharma SRL· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Ah0003 50454: trial site – Frontlight Research